Literature DB >> 9177709

Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.

S P Monkarsh1, Y Ma, A Aglione, P Bailon, D Ciolek, B DeBarbieri, M C Graves, K Hollfelder, H Michel, A Palleroni, J E Porter, E Russoman, S Roy, Y C Pan.   

Abstract

The success of recombinant interferon alpha in the clinic in part is limited by two properties of the protein: short serum half-life and immunogenicity. To improve these properties, interferon alpha-2a was conjugated with polyethylene glycol (PEG-5000). A homogeneous preparation of monopegylated interferon alpha-2a was subjected to vigorous analytical and activity characterization. A newly developed ampholyte-free chromatofocussing-like cation-exchange HPLC method utilizing a sulfopropyl resin was used to separate the monopegylated protein into 11 species. Peptide mapping, sequencing, and mass spectrometric analyses indicated that these species are positional isomers where each isomer represents a single polymer molecule conjugated to one specific lysine residue. No species with a modification at the amino terminus was observed. All 11 isomers show antiviral and antiproliferative activities in the same range as the parent monopegylated interferon alpha-2a.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177709     DOI: 10.1006/abio.1997.2128

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  16 in total

1.  Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development.

Authors:  Howard J Worman; Feng Lin
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

3.  Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.

Authors:  K C Lee; S C Moon; M O Park; J T Lee; D H Na; S D Yoo; H S Lee; P P DeLuca
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG.

Authors:  D C Wylie; M Voloch; S Lee; Y H Liu; S Cannon-Carlson; C Cutler; B Pramanik
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

5.  Biodegradable nanogels for oral delivery of interferon for norovirus infection.

Authors:  Yunjeong Kim; Mahendra Thapa; Duy H Hua; Kyeong-Ok Chang
Journal:  Antiviral Res       Date:  2010-12-07       Impact factor: 5.970

Review 6.  Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Authors:  M L Shiffman
Journal:  Curr Gastroenterol Rep       Date:  2001-02

7.  PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.

Authors:  Jose Ramon; Vivian Saez; Reynier Baez; Raymersy Aldana; Eugenio Hardy
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

8.  Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.

Authors:  Hailong Zhang; Jacob Weingart; Rui Jiang; Jianhao Peng; Qingyu Wu; Xue-Long Sun
Journal:  Bioconjug Chem       Date:  2013-03-15       Impact factor: 4.774

9.  PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.

Authors:  Emily E Reichard; Nisha Nanaware-Kharade; Guillermo A Gonzalez; Shraddha Thakkar; S Michael Owens; Eric C Peterson
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

10.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.